Regulatory Moderna flu vaccine wins unanimous support from FDA panel BioPharma DiveThe endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year.Infectious DiseaseRead full story pharminent June 18, 2026 (Last updated: June 19, 2026) BioPharma Dive The endorsement of an advisory committee positions Moderna to complete a dramatic turnaround for a shot the FDA declined to review earlier this year. Infectious Disease Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Previous PostNext: Next Post Related Stories Regulatory GSK claims FDA okay for first oral carbapenem antibiotic pharminent June 18, 2026 Regulatory uniQure sets course to US filing for Huntington gene therapy pharminent June 17, 2026 Regulatory FDA, Moderna appear aligned on mRNA flu shot heading into adcomm pharminent June 16, 2026
